← feed

Is NCT03487263 results overdue?

Yes — results are overdue. Primary completion was 2018-04-18; the FDAAA-801 reporting deadline (2019-04-18) passed 2667 days ago and no results are posted on ClinicalTrials.gov.

Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease

NCT IDNCT03487263 ↗
SponsorImplicit Bioscience (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2018-04-18 (ACTUAL)
Reporting deadline2019-04-18 (completion + 365d)
Days overdue2667
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 76ea81dc3ccf0954… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03487263. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →